3-(Adamantan-1-yl)-4-ethyl-1-{[4-(2-meth­oxy­phen­yl)piperazin-1-yl]meth­yl}-1H-1,2,4-triazole-5(4H)-thione

In the title compound, C(26)H(37)N(5)OS, the piperazine ring adopts a chair conformation. The triazole ring forms dihedral angles of 67.85 (9) and 59.41 (9)° with the piperazine and benzene rings, respectively, resulting in an approximate V-shaped conformation for the mol­ecule. An intra­molecular C...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Emam, Ali A., Al-Tuwaijri, Hanaa M., Al-Abdullah, Ebtehal S., Chidan Kumar, C. S., Fun, Hoong-Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2013
Materias:
Organic Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914072/
https://www.ncbi.nlm.nih.gov/pubmed/24526973
http://dx.doi.org/10.1107/S1600536813032789
Descripción
Sumario:In the title compound, C(26)H(37)N(5)OS, the piperazine ring adopts a chair conformation. The triazole ring forms dihedral angles of 67.85 (9) and 59.41 (9)° with the piperazine and benzene rings, respectively, resulting in an approximate V-shaped conformation for the mol­ecule. An intra­molecular C—H⋯O hydrogen bond generates an S(6) ring motif. The crystal structure features C—H⋯π inter­actions, producing a two-dimensional supramolecular architecture.

Ejemplares similares